Kohlmann Rebekka, Hoffmann Alexander, Geis Gabriele, Gatermann Sören
Department of Medical Microbiology, Ruhr-University Bochum, Universitaetsstrasse 150, Bochum, Germany; Institute of Medical Laboratory Diagnostics (IML) Bochum GmbH, Castroper Strasse 45, Bochum, Germany.
Institute of Medical Laboratory Diagnostics (IML) Bochum GmbH, Castroper Strasse 45, Bochum, Germany.
Int J Med Microbiol. 2015 Jun-Aug;305(4-5):469-79. doi: 10.1016/j.ijmm.2015.04.004. Epub 2015 Apr 27.
Rapid identification of the causative microorganism is a key element in appropriate antimicrobial therapy of bloodstream infections. Whereas traditional analysis of positive blood cultures requires subculture over at least 16-24h prior to pathogen identification by, e.g. matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), sample preparation procedures enabling direct MALDI-TOF MS, i.e. without preceding subculture, are associated with additional effort and costs. Hence, we integrated an alternative MALDI-TOF MS approach in diagnostic routine using a short incubation on a solid medium.
Positive blood cultures were routinely plated on chocolate agar plates and incubated for 4h (37 °C, 5% CO2). Subsequently, MALDI-TOF MS using a Microflex LT instrument (Bruker Daltonics) and direct smear method was performed once per sample. For successful identification of bacteria at species level, score cut-off values were used as proposed by the manufacturer (≥ 2.0) and in a modified form (≥ 1.5 for MALDI-TOF MS results referring to Gram-positive cocci and ≥ 1.7 for MALDI-TOF MS results referring to bacteria other than Gram-positive cocci). Further data analysis also included an assessment of the clinical impact of the MALDI-TOF MS result.
Applying the modified score cut-off values, our approach led to an overall correct species identification in 69.5% with misidentification in 3.4% (original cut-offs: 49.2% and 1.8%, respectively); for Gram-positive cocci, correct identification in 68.4% (100% for Staphylococcus aureus and enterococci, 80% for beta-hemolytic streptococci), for Gram-negative bacteria, correct identification in 97.6%. In polymicrobial blood cultures, in 72.7% one of the pathogens was correctly identified. Results were not reliable for Gram-positive rods and yeasts. The approach was easy to implement in diagnostic routine. In cases with available clinical data and successful pathogen identification, in 51.1% our approach allowed an optimized treatment recommendation.
MALDI-TOF MS following 4h pre-culture is a valuable tool for rapid pathogen identification from positive blood cultures, allowing easy integration in diagnostic routine and the opportunity of considerably earlier treatment adaptation.
快速鉴定致病微生物是血流感染恰当抗菌治疗的关键要素。传统的阳性血培养分析在通过例如基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)鉴定病原体之前,需要至少16 - 24小时的传代培养,而能够直接进行MALDI-TOF MS(即无需预先传代培养)的样本制备程序会带来额外的工作量和成本。因此,我们在诊断流程中整合了一种替代的MALDI-TOF MS方法,即在固体培养基上进行短时间孵育。
将阳性血培养物常规接种于巧克力琼脂平板上,在37℃、5%二氧化碳条件下孵育4小时。随后,每个样本使用Microflex LT仪器(布鲁克道尔顿公司)进行一次MALDI-TOF MS及直接涂片法检测。为在种水平成功鉴定细菌,按照制造商建议使用评分截断值(≥2.0),并采用修改后的截断值(对于MALDI-TOF MS鉴定革兰氏阳性球菌的结果≥1.5,对于MALDI-TOF MS鉴定除革兰氏阳性球菌以外细菌的结果≥1.7)。进一步的数据分析还包括评估MALDI-TOF MS结果的临床影响。
应用修改后的评分截断值,我们的方法总体正确种属鉴定率为69.5%,错误鉴定率为3.4%(原始截断值分别为49.2%和1.8%);对于革兰氏阳性球菌,正确鉴定率为68.4%(金黄色葡萄球菌和肠球菌为100%,β溶血性链球菌为80%),对于革兰氏阴性菌,正确鉴定率为97.6%。在混合菌血症血培养中,72.7%的病例中能正确鉴定出一种病原体。对于革兰氏阳性杆菌和酵母菌,结果不可靠。该方法易于在诊断流程中实施。在有可用临床数据且成功鉴定病原体的病例中,51.1%的情况下我们的方法能够给出优化的治疗建议。
预培养4小时后的MALDI-TOF MS是从阳性血培养物中快速鉴定病原体的有价值工具,便于整合到诊断流程中,并为更早调整治疗提供了机会。